PARSIPPANY, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or the “Company”), a fully integrated commercial and bioinformatics company that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback